Cathay Biotech Stock Hits Day Low of CNY 43.40 Amid Price Pressure

Cathay Biotech, Inc., a large-cap player in the specialty chemicals sector, experienced a notable decline today, with its stock price dropping by 3.05% to touch an intraday low of CNY 43.40. This performance stands in contrast to the China Shanghai Composite, which saw a minor decrease of 0.11% on the same day. Over the past month, Cathay Biotech has faced challenges, with a decline of 5.17%, while the broader market has only dipped by 1.05%. Year-to-date, the company’s stock has fallen by 12.63%, significantly underperforming the China Shanghai Composite, which has gained 3.1% during the same period. Despite declaring positive results for the last four consecutive quarters, the company has struggled with low management efficiency, reflected in a Return on Capital Employed (ROCE) of 8.99%. Additionally, its long-term growth prospects appear limited, with net sales growing at an annual rate of 13.42% and operating profit declining by 4.13% over the last five years. Cathay Biotech's current market capitalization stands at CNY 25,663 million, with a Price to Book ratio of 1.44 and a dividend yield of 0.91%.